ENTHYMIC
Live / Registered — Registered (as of 10 Mar 2020)
What this means for you
Registered since 10 Mar 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88319644
- Registration number
- 6005358
- Mark type
- Stylized text
- Filed
- 28 Feb 2019
- Published for opposition
- 24 Dec 2019
- Registered
- 10 Mar 2020
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment of pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; pharmaceutical preparations for human use, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes for the treatment of pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto
Owner
- SUMITOMO PHARMA SWITZERLAND GMBH, BASEL, CH
- Enzyvant Therapeutics GmbH, Basel, CH
- Enzyvant Therapeutics GmbH, Basel, CH
- Enzyvant Therapeutics GmbH, Basel, CH
Prosecution history
- 18 Mar 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 10 Mar 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Mar 2020 — REGISTERED-PRINCIPAL REGISTER
- 24 Dec 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Dec 2019 — PUBLISHED FOR OPPOSITION
- 04 Dec 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Nov 2019 — ASSIGNED TO LIE
- 16 Nov 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Oct 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Oct 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Oct 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Jul 2019 — ASSIGNED TO EXAMINER
- 16 May 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 May 2019 — NON-FINAL ACTION E-MAILED
- 16 May 2019 — NON-FINAL ACTION WRITTEN